Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Qingdao Sino-Cell Biomedicine Co., Ltd..
Real, source-linked trial activity for Qingdao Sino-Cell Biomedicine Co., Ltd.: 2 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 22, 2026. Source-linked, daily-refreshed.
PHASE1 2
Newest Qingdao Sino-Cell Biomedicine Co., Ltd. trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | A Clinical Study of HS-IT101 Injection in Patients With Advanced Non-S | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 35d ago | Clinical Study of HS-IT101 Injection in the Treatment of Advanced Rena | Ph 1 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Qingdao Sino-Cell Biomedicine Co., Ltd. (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.